$114 Million is the total value of Healthcare Value Capital, LLC's 50 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MDY | SPDR S&P MIDCAP 400 ETF TRput | $5,658,000 | +7.7% | 25,000 | 0.0% | 4.95% | +29.9% | |
| AZN | ASTRAZENECA PLCsponsored adr | $4,271,000 | +9.8% | 82,239 | 0.0% | 3.74% | +32.4% | |
| SPY | SPDR S&P 500 ETF TRput | $4,200,000 | +4.7% | 25,000 | 0.0% | 3.67% | +26.3% | |
| DGX | QUEST DIAGNOSTICS INC | $4,153,000 | +1.9% | 67,208 | 0.0% | 3.63% | +22.9% | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $2,306,000 | +0.4% | 45,966 | 0.0% | 2.02% | +21.1% | |
| GIVN | GIVEN IMAGING | $2,114,000 | +37.3% | 109,950 | 0.0% | 1.85% | +65.5% | |
| ACT | ACTAVIS INC | $1,803,000 | +14.0% | 12,524 | 0.0% | 1.58% | +37.6% | |
| SNY | SANOFIsponsored adr | $1,657,000 | -1.7% | 32,735 | 0.0% | 1.45% | +18.6% | |
| CRY | CRYOLIFE INC | $828,000 | +11.9% | 118,288 | 0.0% | 0.72% | +34.8% | |
| ZGNX | ZOGENIX INC | $511,000 | +8.0% | 276,336 | 0.0% | 0.45% | +30.3% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $413,000 | -4.4% | 83,185 | 0.0% | 0.36% | +15.3% | |
| ANAC | ANACOR PHARMACEUTICALS INC | $401,000 | +90.0% | 37,730 | 0.0% | 0.35% | +129.4% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $394,000 | +86.7% | 100,000 | 0.0% | 0.34% | +125.5% | |
| CRY | CRYOLIFE INCcall | $279,000 | +11.6% | 39,900 | 0.0% | 0.24% | +34.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.